CU Innovations Wins $50,000 Grant to Support Diversity in Entrepreneurship and Innovation
Many studies have shown that companies with diverse leadership and innovation teams are the most successful and profitable.
-
-
University of Colorado Received $1.45 Billion in Research Funding in 2021
Faculty within the University of Colorado system received a total of $1.45 billion in sponsored research funding and research gifts this year…
-
Even with Constrained Lab Space, Denver Ranks as a Top Bioscience Market
The Denver-Boulder market ranks among the top 10 bioscience markets in the U.S and Canada, according to a new report…
-
Gates Biomanufacturing Facility Announces Strategic Manufacturing Agreement with Cell Therapy Pioneer, Nkarta
The Gates Biomanufacturing Facility announced a continued strategic agreement with Nkarta, Inc. to manufacture clinical supply of therapeutic Natural Killer (NK) cells.
-
What’s Next for Liquid Biopsy Tests?
Aurora, Colo.-based Foresight Diagnostics, which was co-founded in 2020 by Jake Chabon, PhD, Max Diehn, MD, PhD, Ash Alizadeh, MD, PhD, and David Kurtz, MD PhD, has developed a new liquid biopsy test that can identify the earliest hint of cancer recurrence.
-
Zalgen Awarded CEPI Contract to Provide Test Kits for Largest Ever Lassa Fever Study in West Africa
Three-year contract leading to advance clinical trials for Lassa Fever vaccines reaffirms Zalgen’s focus on preparedness and its dedication to developing solutions for emerging viral threats.
-
AC-REP Visits Fitzsimons Innovation Community to Showcase Adams County’s Business Advantages and Opportunities During the Fourth-Annual Site Selection Summit
Adams County Regional Economic Partnership (AC-REP) hosted its fourth-annual Site Selection Summit focused on promoting the business advantages of Adams County, Colorado.
-
Fitzsimons Innovation Community Breaks Ground on First Full-Scale Commercial Manufacturing Facility, for Cell and Gene Therapy
Fitzsimons Innovation Community breaks ground on its new bioscience building, Bioscience 5, further delivering on the Community’s vision to advance health and care….
-
Cerebral Therapeutics, Inc. Names Guy Anthony as Chief Financial Officer
Cerebral Therapeutics, clinical-stage pharmaceutical company developing innovative treatments for neurological disease, has appointed Guy Anthony as Chief Financial Officer.
-
